Millenium Biologix ("Millenium") announced September 6 that it has been awarded a key continuation of the initial Canadian Space Agency contract to develop an automated osteoporosis mini lab for space missions.
The first of this series of space contracts for the Enhanced OSTeoporosis Experiments in Orbit ("eOSTEO") was announced in May 2005.
This contract amendment progresses eOSTEO through a formal CSA-driven Detailed Design Phase and brings the total value to date from this series of contracts to $726,000. Subsequent contracts are expected to progress the program through Fight Hardware Manufacture, and Science and Mission Support.
About The OSTeoporosis Experiments in Orbit
